Mayo Clinic researchers identify new strategies to target cellular senescence

Researchers at the Mayo Clinic have published a series of seven studies detailing the mechanisms of senescent cells, often referred to as zombie cells, ScienceDaily and Technology Org reported. These aging cells permanently stop dividing but remain metabolically active, secreting inflammatory signals that damage surrounding tissues and accelerate physical decline. [1][2][5]

According to ScienceDaily, the findings outline new methods to selectively target these lingering cells. In laboratory trials involving aging mice, experimental interventions led to reduced systemic inflammation and caused measurable improvements in both physical function and cognitive performance. [1][2]

Among the strategies tested, ScienceDaily reported that researchers identified a natural compound found in tomatoes that helps neutralize senescent cell activity. The collection of studies maps out how these dysfunctional cells age the body and provides potential pathways for therapeutic drugs to slow down age-related degeneration. [1][2][5]

The Mayo Clinic is a private American academic medical center focused on healthcare, research, and education, operating primary campuses in Minnesota, Florida, and Arizona. Research into cellular senescence aims to establish targets for human clinical trials to address chronic diseases driven by aging. [1][5][7]